The US Food and Drug Administration has approved the use of the injectable drug tocilizumab for the treatment of giant cell arteritis, making it the first approved drug for this condition. Giant cell arteritis is an inflammatory disease belonging to a group of conditions referred to as vasculitis. It affects medium and large blood vessels, mainly supplying to the head and neck region, thereby affecting blood flow through them.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer